Dr. Mills co-founded BioStorage Technologies Inc. (BST) in 2002, recognizing the need for the biopharmaceutical industry to store and manage samples for future biomarker and target identification as well as for analyses performed to meet regulatory requirements. He grew BST through angel and series A funding to a global company that was acquired by Brooks Automation in December 2015.

Since that time, he has been Chairman of DGP Intelsius Ltd., a UK headquartered company specializing in global cold chain packaging solutions. He also serves on the boards of hc1.com, a pioneer in healthcare relationship management and Diversigen Inc., an early stage Company at Baylor College of Medicine. He has also been a director of IBT Labs and Chantest, both of which were acquired in successful transactions. Before founding BST, Dr. Mills served for four years as corporate senior vice president and president of clinical support services for Covance, Inc., a leading contract research organization headquartered in Princeton, New Jersey. While there, he was responsible for a clinical services division that employed more than 2,000 staff globally. From 1991 to 1998 he was corporate vice president and president of Covance’s clinical business in Europe, operating in 14 countries.

Prior to 1991, Dr. Mills held senior positions for Johnson and Johnson’s pharmaceutical division in Asia (based in Singapore) and the U.K. From 1976 to 1982 he served in the Royal Air Force as a specialist in Aviation Medicine at Farnborough, UK. Dr. Mills received his MD from Cambridge University and his PhD in endocrinology from Surrey University in the United Kingdom. He holds diplomas in pharmaceutical medicine, aviation medicine and marketing and has authored more than 40 scientific papers as well as a textbook on aviation medicine.